GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » YoY EBITDA Growth

Optimind Pharma (XCNQ:OMND) YoY EBITDA Growth : 66.67% (As of Nov. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Optimind Pharma's YoY EBITDA Growth for the quarter that ended in Nov. 2023 was 66.67%.

Optimind Pharma's EBITDA per Share for the three months ended in Nov. 2023 was C$-0.00.


Optimind Pharma YoY EBITDA Growth Historical Data

The historical data trend for Optimind Pharma's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma YoY EBITDA Growth Chart

Optimind Pharma Annual Data
Trend Feb22 Feb23
YoY EBITDA Growth
- -

Optimind Pharma Quarterly Data
Jun21 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
YoY EBITDA Growth Get a 7-Day Free Trial -200.00 -900.00 - 77.78 66.67

Optimind Pharma YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Optimind Pharma's YoY EBITDA Growth for the fiscal year that ended in Feb. 2023 is calculated as:

YoY EBITDA Growth (A: Feb. 2023 )
=(EBITDA per Share (A: Feb. 2023 )-EBITDA per Share (A: Feb. 2022 ))/ | EBITDA per Share (A: Feb. 2022 ) |
=(-0.036-0)/ | 0 |
=N/A %

Optimind Pharma's YoY EBITDA Growth for the quarter that ended in Nov. 2023 is calculated as:

YoY EBITDA Growth (Q: Nov. 2023 )
=(EBITDA per Share (Q: Nov. 2023 )-EBITDA per Share (Q: Nov. 2022 )) / | EBITDA per Share (Q: Nov. 2022 )) |
=(-0.001--0.003)/ | -0.003 |
=66.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Optimind Pharma YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Optimind Pharma (XCNQ:OMND) Business Description

Traded in Other Exchanges
N/A
Address
3000 - 77 King Street West, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8
Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities.

Optimind Pharma (XCNQ:OMND) Headlines

No Headlines